Rybelsus (oral semaglutide) is FDA-approved for type 2 diabetes, but some physicians prescribe it off-label for weight loss. While it can help non-diabetic patients reduce weight, risks and side effects remain similar, and alternatives like Wegovy are often more effective for obesity management.